top of page

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August - 2 Septemb

During its September meeting, the European Medicines Agency's (EMA)Pharmacovigilance Risk Assessment Committee (PRAC) discussed one ongoing safetyreferral. It did not initiate or conclude a referral.

Click on this link for more information.


Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page